Rigel Pharmaceuticals Inc (RIGL)
25.98
+0.94
(+3.75%)
USD |
NASDAQ |
Nov 22, 11:37
Rigel Pharmaceuticals Shareholders Equity (Quarterly): -14.64M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -14.64M |
June 30, 2024 | -29.91M |
March 31, 2024 | -31.67M |
December 31, 2023 | -28.64M |
September 30, 2023 | -31.83M |
June 30, 2023 | -28.12M |
March 31, 2023 | -24.26M |
December 31, 2022 | -13.62M |
September 30, 2022 | -19.83M |
June 30, 2022 | -3.677M |
March 31, 2022 | 6.798M |
December 31, 2021 | 30.37M |
September 30, 2021 | 49.67M |
June 30, 2021 | 68.11M |
March 31, 2021 | 78.30M |
December 31, 2020 | 34.03M |
September 30, 2020 | 50.96M |
June 30, 2020 | 63.21M |
March 31, 2020 | 78.50M |
December 31, 2019 | 53.82M |
September 30, 2019 | 68.91M |
June 30, 2019 | 78.29M |
March 31, 2019 | 95.32M |
December 31, 2018 | 109.88M |
September 30, 2018 | 103.47M |
Date | Value |
---|---|
June 30, 2018 | 123.57M |
March 31, 2018 | 79.81M |
December 31, 2017 | 100.65M |
September 30, 2017 | 56.17M |
June 30, 2017 | 69.60M |
March 31, 2017 | 84.08M |
December 31, 2016 | 55.03M |
September 30, 2016 | 65.94M |
June 30, 2016 | 73.72M |
March 31, 2016 | 75.45M |
December 31, 2015 | 91.38M |
September 30, 2015 | 96.41M |
June 30, 2015 | 101.15M |
March 31, 2015 | 112.15M |
December 31, 2014 | 128.25M |
September 30, 2014 | 146.85M |
June 30, 2014 | 165.73M |
March 31, 2014 | 188.33M |
December 31, 2013 | 208.25M |
September 30, 2013 | 223.40M |
June 30, 2013 | 245.05M |
March 31, 2013 | 265.31M |
December 31, 2012 | 289.10M |
September 30, 2012 | 174.80M |
June 30, 2012 | 195.75M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-31.83M
Minimum
Sep 2023
78.50M
Maximum
Mar 2020
14.38M
Average
1.560M
Median
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 1.072M |
Palatin Technologies Inc | -7.686M |
iBio Inc | 17.75M |
Theriva Biologics Inc | 24.64M |
Oragenics Inc | 3.078M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 139.42M |
Total Liabilities (Quarterly) | 154.06M |
Debt to Equity Ratio | -4.083 |
Current Ratio | 1.960 |
Net Debt Paydown Yield | -0.01% |